Laboratory Corporation of America (LH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Laboratory Corporation of America Revenue Highlights


Latest Revenue (Y)

$12.16B

Latest Revenue (Q)

$3.28B

Main Segment (Y)

Diagnostics

Main Geography (Y)

North America

Laboratory Corporation of America Revenue by Period


Laboratory Corporation of America Revenue by Year

DateRevenueChange
2023-12-31$12.16B-18.25%
2022-12-31$14.88B-7.72%
2021-12-31$16.12B15.33%
2020-12-31$13.98B20.98%
2019-12-31$11.55B1.95%
2018-12-31$11.33B8.54%
2017-12-31$10.44B8.29%
2016-12-31$9.64B11.08%
2015-12-31$8.68B44.39%
2014-12-31$6.01B3.50%
2013-12-31$5.81B2.41%
2012-12-31$5.67B2.33%
2011-12-31$5.54B10.76%
2010-12-31$5.00B6.59%
2009-12-31$4.69B4.21%
2008-12-31$4.51B10.74%
2007-12-31$4.07B13.30%
2006-12-31$3.59B7.91%
2005-12-31$3.33B7.87%
2004-12-31$3.08B4.95%
2003-12-31$2.94B17.21%
2002-12-31$2.51B14.00%
2001-12-31$2.20B14.61%
2000-12-31$1.92B12.99%
1999-12-31$1.70B5.34%
1998-12-31$1.61B6.16%
1997-12-31$1.52B-5.52%
1996-12-31$1.61B12.27%
1995-12-31$1.43B64.13%
1994-12-31$872.50M14.73%
1993-12-31$760.50M-

Laboratory Corporation of America generated $12.16B in revenue during NA 2023, up -18.25% compared to the previous quarter, and up 107.31% compared to the same period a year ago.

Laboratory Corporation of America Revenue by Quarter

DateRevenueChange
2024-09-30$3.28B1.90%
2024-06-30$3.22B1.39%
2024-03-31$3.18B4.72%
2023-12-31$3.03B-0.77%
2023-09-30$3.06B0.76%
2023-06-30$3.03B-19.70%
2023-03-31$3.78B2.82%
2022-12-31$3.67B1.89%
2022-09-30$3.61B-2.46%
2022-06-30$3.70B-5.20%
2022-03-31$3.90B-3.86%
2021-12-31$4.06B-0.16%
2021-09-30$4.06B5.78%
2021-06-30$3.84B-7.71%
2021-03-31$4.16B-7.31%
2020-12-31$4.49B15.24%
2020-09-30$3.90B40.71%
2020-06-30$2.77B-1.95%
2020-03-31$2.82B-4.39%
2019-12-31$2.95B0.85%
2019-09-30$2.93B1.62%
2019-06-30$2.88B3.24%
2019-03-31$2.79B0.13%
2018-12-31$2.79B-1.55%
2018-09-30$2.83B-1.22%
2018-06-30$2.87B0.63%
2018-03-31$2.85B1.86%
2017-12-31$2.80B5.31%
2017-09-30$2.66B4.42%
2017-06-30$2.54B3.92%
2017-03-31$2.45B0.77%
2016-12-31$2.43B0.57%
2016-09-30$2.41B-0.66%
2016-06-30$2.43B2.65%
2016-03-31$2.37B2.19%
2015-09-30$2.32B2.12%
2015-06-30$2.27B26.54%
2015-03-31$1.79B18.54%
2014-12-31$1.51B-2.52%
2014-09-30$1.55B2.33%
2014-06-30$1.52B5.99%
2014-03-31$1.43B-0.44%
2013-12-31$1.44B-1.72%
2013-09-30$1.46B-0.41%
2013-06-30$1.47B1.89%
2013-03-31$1.44B2.53%
2012-12-31$1.41B-0.99%
2012-09-30$1.42B-0.28%
2012-06-30$1.42B0.01%
2012-03-31$1.42B4.19%
2011-12-31$1.37B-2.73%
2011-09-30$1.40B0.09%
2011-06-30$1.40B2.55%
2011-03-31$1.37B5.64%
2010-12-31$1.30B1.48%
2010-09-30$1.28B3.08%
2010-06-30$1.24B3.75%
2010-03-31$1.19B2.45%
2009-12-31$1.17B-1.69%
2009-09-30$1.19B-0.31%
2009-06-30$1.19B2.86%
2009-03-31$1.16B3.27%
2008-12-31$1.12B-1.41%
2008-09-30$1.14B-1.11%
2008-06-30$1.15B4.04%
2008-03-31$1.10B9.68%
2007-12-31$1.01B-

Laboratory Corporation of America generated $3.28B in revenue during Q2 2024, up 1.90% compared to the previous quarter, and up 108.18% compared to the same period a year ago.

Laboratory Corporation of America Revenue Breakdown


Laboratory Corporation of America Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 19Dec 18
Diagnostics$9.20B$20.73B--
Drug Development$5.71B$11.69B--
Covance Drug Development--$4.58B$4.31B
LabCorp Diagnostics--$7.00B$7.03B

Laboratory Corporation of America's latest annual revenue breakdown by segment (product or service), as of Dec 22: Diagnostics (61.71%), and Drug Development (38.29%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Covance Drug Development$737.70M$707.00M$710.90M---
LabCorp Diagnostics$2.55B$2.52B$2.48B---
Diagnostics--$2.48B$9.42B$2.34B$2.34B
Drug Development--$710.90M$2.77B$719.10M$699.00M

Laboratory Corporation of America's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: LabCorp Diagnostics (77.59%), and Covance Drug Development (22.41%).

Laboratory Corporation of America Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19Dec 18
Europe$2.05B$1.51B--
Other countries$976.40M$941.00M$1.20B$1.18B
North America$13.09B$11.53B--

Laboratory Corporation of America's latest annual revenue breakdown by geography, as of Dec 21: North America (81.22%), Europe (12.72%), and Other countries (6.06%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Sep 23Jun 23
UNITED STATES$2.74B$2.70B$2.65B$2.55B$2.54B

Laboratory Corporation of America's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (100.00%).

Laboratory Corporation of America Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
HUMHumana$106.44B$29.40B
UHSUniversal Health Services$14.28B$3.96B
LHLaboratory Corporation of America$12.16B$3.28B
DGXQuest Diagnostics$9.25B$2.49B
HOLXHologic$4.03B$1.01B
WATWaters$2.96B$740.30M

LH Revenue FAQ


What is Laboratory Corporation of America’s yearly revenue?

Laboratory Corporation of America's yearly revenue for 2023 was $12.16B, representing a decrease of -18.25% compared to 2022. The company's yearly revenue for 2022 was $14.88B, representing a decrease of -7.72% compared to 2021. LH's yearly revenue for 2021 was $16.12B, representing an increase of 15.33% compared to 2020.

What is Laboratory Corporation of America’s quarterly revenue?

Laboratory Corporation of America's quarterly revenue for Q2 2024 was $3.28B, a 1.90% increase from the previous quarter (Q1 2024), and a 7.37% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.22B, a 1.39% increase from the previous quarter (Q4 2023), and a 6.17% increase year-over-year (Q1 2023). LH's quarterly revenue for Q4 2023 was $3.18B, a 4.72% increase from the previous quarter (Q3 2023), and a -15.92% decrease year-over-year (Q4 2022).

What is Laboratory Corporation of America’s revenue growth rate?

Laboratory Corporation of America's revenue growth rate for the last 3 years (2021-2023) was -24.56%, and for the last 5 years (2019-2023) was 5.25%.

What are Laboratory Corporation of America’s revenue streams?

Laboratory Corporation of America's revenue streams in c 22 are Diagnostics, and Drug Development. Diagnostics generated $9.2B in revenue, accounting 61.71% of the company's total revenue, down -55.60% year-over-year. Drug Development generated $5.71B in revenue, accounting 38.29% of the company's total revenue, down -51.16% year-over-year.

What is Laboratory Corporation of America’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Laboratory Corporation of America was Diagnostics. This segment made a revenue of $9.2B, representing 61.71% of the company's total revenue.